Article Details

IndexIQ Advisors LLC Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)

Retrieved on: 2022-08-10 21:26:37

Tags for this article:

Click the tags to see associated articles and topics

IndexIQ Advisors LLC Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT). View article details on hiswai:

Excerpt

It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up